← All Wire coverage

Situationmaterial

U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb's First CELMoD Therapy ...

Carried more widely than almost anything else in the last 30 days

Reports

12

Domains carrying it

12

First reported

13 August 2026

Latest report

17 August 2026

Sectors

Biotech

Where

United States

Timeline

  1. 13 August 2026U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb's First CELMoD Therapy ...lasvegassun.com
  2. 14 August 2026Bristol Myers wins 'milestone' FDA approval of myeloma drug acquired from Celgenebiopharmadive.com
  3. 15 August 2026Bristol Myers Squibb Wins FDA Approval for Its First CELMoD Drug, Aimed at Multiple ...biobuzz.io
  4. 17 August 2026Bristol Myers Squibb Wins FDA Accelerated Approval For ZENBEXUS In Multiple Myelomaarttnews.com
  5. 17 August 2026FDA approves Zenbexus for multiple myeloma; NSAI seeks buyer for its MDR notified body businessraps.org

Connected developments

Situations Wire finds semantically close to this one. Proximity, not cause.

Share

Wire has not analysed this situation yet

Below is every report Wire has gathered on this event, and the situations it connects to. The deeper analysis — why it happened, what changed, what would prove it wrong — is not written yet, so nothing here claims it.

Evidence

12 reports · 12 domains